Abstract:Abstract Spatial omics technologies are producing an unprecedented amount of ultra-high plex in situ data that are promising to revolutionize cancer prognoses and treatments. Analytical solutions to integrate big spatial data are, however, lagging relative to the rapid technology development and this hinders discoveries into the pathological processes underlying cancer initiation and progression. Here we present STimage, a machine learning approach to flexibly combine transcriptome-wide spatial sequencing data with single-cell protein-based spatial phenotyping (Phenocycler-Fusion), generated from same tissue samples. As a ground-truth for cell typing, Akoya’s single-cell spatial phenotyping technology enabled us to precisely define cell types and cell states that were then used to evaluate and deploy the data integration pipeline. With these data, STimage first maps cells onto tissue sections with reference an H&E image. This way multiple layers of molecular data are transferred into one common framework, which can then be analyzed together. Traditional pathology annotations on the H&E images are also integrated to add human understanding of morphological patterns in a cancer tissue. The integrated analysis improves cell neighborhood identification, which allows cell-cell interaction analysis based on spatial co-localization between cell types (using single-cell resolution protein data) and locally co-expressing ligand-receptor pairs (using transcriptome-wide spatial data). We applied STimage to head and neck and skin cancer samples, in order to demonstrate the broad applicability of this analysis pipeline for various cancer types. We demonstrate applications for both, diagnoses and prognoses. For diagnosis, ST image identified and cross-validated cell types whilst assessing the expression of markers for drug targets. We also present an in-depth case study for an oropharyngeal squamous cell carcinoma patient not responding to Nivolumab treatment (anti-PD-1). Based on Visium and PhenoCycler-Fusion data, we discovered a spatial signature for non-responsiveness. Furthermore, we used the predicted ligand-receptor interactions to rank the patient’s response potential to currently available drugs, with the top target being TF-TFRC. STimage is thus able to integrate multiple layers of spatial omics data to improve and solidify prognostic biomarkers for cancer treatments. This study highlights the power of machine learning integration to combine multiple spatial multi-omics data, in particular PhenoCycler-Fusion and Visium, for improving diagnosis, prognosis and treatment of diverse cancers. Citation Format: Xiao Tan, Andrew Causer, Jazmina Gonzales-Cruz, Ning Ma, Bassem Ben Cheikh, Oliver Braubach, Quan Nguyen. Machine learning integration of transcriptome-wide spatial sequencing data and ultra-high plex spatial proteomic data enables the prioritization of cancer drug targets [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2059.

Spatial-And-Context aware (SpACe) "virtual biopsy" radiogenomic maps to target tumor mutational status on structural MRI

Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer

Path2Space: An AI Approach for Cancer Biomarker Discovery Via Histopathology Inferred Spatial Transcriptomics

Mapping Whole Exome Sequencing to In Vivo Imaging with Stereotactic Localization and Deep Learning

Abstract 2059: Machine learning integration of transcriptome-wide spatial sequencing data and ultra-high plex spatial proteomic data enables the prioritization of cancer drug targets

Knowledge-infused Global-Local Data Fusion for Spatial Predictive Modeling in Precision Medicine

MRI radiogenomics for intelligent diagnosis of breast tumors and accurate prediction of neoadjuvant chemotherapy responses-a review

Conditional generative adversarial network driven radiomic prediction of mutation status based on magnetic resonance imaging of breast cancer

Tumor-Associated Tractography Derived from High-Angular-Resolution Q-Space MRI May Predict Patterns of Cellular Invasion in Glioblastoma

Radiogenomic classification for MGMT promoter methylation status using multi-omics fused feature space for least invasive diagnosis through mpMRI scans

Abstract 5496: Multi-omic spatial analysis of the tumor microenvironment in gliomas

Inferring spatial transcriptomics markers from whole slide images to characterize metastasis-related spatial heterogeneity of colorectal tumors: A pilot study

Radiomics Multifactorial In-Silico Model for Spatial Prediction of Glioblastoma Progression and Recurrence: A Proof-of-Concept

From Voxel to Gene: A Scoping Review on MRI Radiogenomics' Artificial Intelligence Predictions in Adult Gliomas and Glioblastomas-The Promise of Virtual Biopsy?

Spatially Structured Regression for Non-conformable Spaces: Integrating Pathology Imaging and Genomics Data in Cancer

Epco-03. Metabolic Insight Into Glioma Heterogeneity: Mapping Whole Exome Sequencing Toin Vivo Imaging With Stereotactic Localization And Deep Learning

RADIOHEAD: Radiogenomic Analysis Incorporating Tumor Heterogeneity in Imaging Through Densities

Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma

Glioblastoma multiforme prognosis: MRI missing modality generation, segmentation and radiogenomic survival prediction

NIMG-82. RADIOGENOMIC SIGNATURES OF KEY DRIVER GENES IN GBM REVEAL MOLECULAR HETEROGENEITY OF THE TUMOR MICROENVIRONMENT LINKED TO SPATIAL DISTRIBUTION: IMPACT ON THE TRAJECTORY OF GLIOMA EVOLUTION

NIMG-66. RADIOGENOMICS-BASED HETEROGENEITY ANALYSIS OF GLIOBLASTOMA REVEALS MR IMAGING PHENOTYPICAL CHARACTERIZATION OF EGFR MUTATIONS